Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
This study in patients with IBS-C is a randomized, double-blind, placebo-controlled,
parallel-group clinical trial with 12 weeks of study drug therapy.
Phase:
Phase 3
Details
Lead Sponsor:
Bausch Health Americas, Inc. Synergy Pharmaceuticals Inc.